Old Web
English
Sign In
Acemap
>
Paper
>
OC-0086: A sarcoma hypoxia signature (nanoString® assay) validates in the phase III VorteX radiotherapy trial
OC-0086: A sarcoma hypoxia signature (nanoString® assay) validates in the phase III VorteX radiotherapy trial
2020
L. Forker
B. Bibby
Lingjian Yang
Joely J Irlam
Helen R Valentine
P. Shenjere
James P Wylie
M. Leahy
Piers Gaunt
Lucinda Billingham
Max Robinson
Ananya Choudhury
Catharine M L West
Keywords:
Vortex
Cancer research
Hypoxia (medical)
Radiation therapy
Sarcoma
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]